Using transgenic animal models in neuroendocrine research: lessons from Xenopus laevis.
Transgenic animals are commonly employed to explore the function of individual proteins. Transgenic animal models include the mouse, the zebrafish, and the South African clawed toad Xenopus laevis. In contrast to mice and zebrafish, with Xenopus transgenesis DNA integration is mostly achieved in the one-cell stage. Moreover, Xenopus (as well as zebrafish) eggs are relatively large, the embryos are transparent, a large offspring is generated, and maintenance of the offspring is easy. In our transgenic studies in Xenopus, we focus on the well-characterized neuroendocrine melanotrope cells of the pituitary pars intermedia that are regulated during the process of adaptation of Xenopus to a changing environment. When the animal is placed on a black background, the melanotrope cells produce and process large amounts of the prohormone proopiomelanocortin (POMC). We apply stable melanotrope-specific transgenesis that is achieved by mixing a Xenopus POMC-promoter/transgene construct with sperm nuclei and injecting this mixture into unfertilized eggs. Since in the melanotrope cells the POMC promoter is much more active in black-adapted animals, the level of transgene expression can be manipulated by placing the animal on either a black or a white background. In this paper we review the possibilities of the Xenopus melanotrope-specific transgenic approach. Following a brief overview of the functioning of Xenopus melanotrope cells, stable melanotrope-specific transgenesis is discussed and our transgenic studies on brain-derived neurotrophic factor and secretory pathway components are described as examples of the transgenic approach in a physiological context and close to the in vivo situation.
Scheenen
W J J M
WJ
Department of Cellular Animal Physiology, European Graduate School of Neuroscience, Faculty of Science, Radbound University Nijmegen, Nijmegen, The Netherlands. w.scheenen@science.ru.nl
Jansen
E J R
EJ
Roubos
E W
EW
Martens
G J M
GJ
D000818:Animals; D030801:Animals, Genetically Modified; D005786:Gene Expression Regulation; D006801:Humans; D023421:Models, Animal; D009490:Neurosecretory Systems / Q000378:metabolism*; D011333:Pro-Opiomelanocortin / Q000378:metabolism; D014982:Xenopus laevis / Q000378:metabolism*
D011333:Pro-Opiomelanocortin